Myra E. van Linde

Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis

Myra E. van Linde, Cyrillo G. Brahm, Philip C. De Witt Hamer et al. · Journal of Neuro-Oncology · 2017 · 198 citations · Full text

Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma

Joost J.C. Verhoeff, Cristina Lavini, Myra E. van Linde et al. · Annals of Oncology · 2010 · 91 citations · Full text

Dose-intense Temozolomide, Medicine, Brain Tumor Biology +6

Study protocol of a phase IB/II clinical trial of metformin and chloroquine in patients with <i>IDH1</i> -mutated or <i>IDH2</i> -mutated solid tumours

Remco J. Molenaar, Robert J.S. Coelen, Mohammed Khurshed et al. · BMJ Open · 2017 · 79 citations · Full text

Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, <i>IDH</i> -wildtype: <i>Post Hoc</i> Analysis of the EORTC Randomized Phase III CATNON Trial

C. Mircea S. Tesileanu, Marc Sanson, Wolfgang Wick et al. · Clinical Cancer Research · 2022 · 68 citations · Full text

Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma

C. Mircea S. Tesileanu, Martin J. van den Bent, Marc Sanson et al. · Neuro-Oncology · 2021 · 59 citations · Full text